Effect of vegetable oil on ovarian steroidogenesis- A transcriptome approach to understand molecular mechanisms of hypothalamus pituitary and gonad axis (HPG) in Ompok bimaculatus Authors: Sagar Chandra Mandal, Partha Sarathi Tripathy, Ananya Khatei, Ningthoujam Chaoba Devi, Pradyut Biswas, Jitendra Kumar Sundaray, Farhana Hoque, Janmejay Parhi, Amel Mohamed El Asely, Amel Mohamed El Asely, Amel Mohamed El Asely Published: 2024 ABSTRACT Ompok bimaculatus is a commercially important food fish of Northeast India. For higher production of this species, the molecular mechanisms underlying its reproductive physiology is an important aspect to study. Vegetable oils are rich in ω3 and ω6 fatty acids and fat-soluble vitamins, that enhance reproductive performances. In the present study, O. bimaculatus were first fed with vegetable oil at 3, 5, 7 and 9% in the diet. The best treatment was determined by the analysis of relative fecundity, fertilisation rate, Gonadosomatic Index (GSI) and Hepatosomatic Index (HIS). Comparative transcriptomics analysis of gonadal tissues between control and best treatment was done using Illumina NextSeq500. The bioinformatics analysis by Trinity v2.11.0 and edgeR v3.32.1 identified 36 DEGs related to reproduction, those were later validated by qPCR analysis. The Differentially Expressed Genes (DEGs) revealed, regulation of Hypothalamic—pituitary—gonadal axis (HPG) axis through retinoid signalling pathway, IGF pathway and folliculogenesis pathway, including inhibitory effects of dietary vegetable oil on fish gonadal maturation. 1. Introduction Lipids play significant roles as sources of metabolic energy for growth and reproduction in fishes. Large amounts of lipids are required both for egg production and breeding activities [1, 2]. During maturation and spawning, there is a need for high energy in the gonads. The lipid stored in the liver and muscles is transferred and move to the gonad [3]. In adult fishes, different lipid classes in gonads, liver and muscle influence sexual maturation and spawning [4, 5]. Essential fatty acids (EFA), particularly docosahexaenoic acid (DHA: 22:6n-3) and eicosapentaenoic acid (EPA: 20:5n-3), are one of the major nutritional factors significantly affecting reproductive performance in fish [6]. Phospholipids are the primary lipid required during egg yolk development, embryonic and early larval development in fishes [7]. Polyunsaturated fatty acids like arachidonic acid (AA:20:4n-6) is also considered as an essential compound because of their involvement in the production of eicosanoid [8], particularly prostaglandins, which are involved in several reproductive processes including the production of steroid hormones and gonadal development such as ovulation [9]. Most fish cannot synthesise n-3 and n-6 PUFA de novo so, they must be supplied in the diet. High unsaturated fatty acid (HUFA) and polyunsaturated fatty acids (PUFA) in brooder feed significantly affect fecundity, fertility, hatching, and viability of fish eggs and larval physiological fitness [10, 11]. Ompok bimaculatus (Pabda) is a highly demanded fish species in aquaculture, especially in eastern and northeastern India and Bangladesh, because of its good taste and flavor [12]. The fish has been recognized as the state fish of Tripura. Various efforts are made to improve brood stock quality to produce sufficient and good quality offspring for high production. This study aims to evaluate the effects of dietary vegetable oil inclusion on the molecular reproductive processes in Pabda. Specifically, the study investigates the reproductive genes, which are numerous and associated with processes from gonadal development to the release of milt and oocyte. The transcriptomic study focuses on the whole transcripts (RNA) transcribed from a given cell or tissue type at a particular time [13]. Comparative transcriptomics provides information on the differential expression patterns of important genes between treated and control groups. Therefore, to understand the molecular mechanisms of dietary vegetable oil supplements on the reproductive process, a comparative transcriptomics analysis was carried out. This approach identifies a set of reproductive genes responsible for reproduction and spawning using an OMICS approach and further validates these findings using qPCR. 2. Materials and methods 2.1. Ethical statement All the fish specimens of O. bimaculatus used in this study were collected from the third generation of domesticated stock in the Wet Lab of College of Fisheries, CAU (Imphal), Tripura, India. Ethical approval, specimen collection and maintenance were performed strictly according to ethical standards of the Institute’s Animal Ethics Committee, College of Fisheries, Central Agricultural University, Imphal, India (IAEC/COF-CAU No. A8/213422/2021). The fish were humanely euthanized using an overdose of tricaine methanesulfonate (MS-222) at a concentration of 300 mg/L, followed by decapitation to ensure death. Anesthesia was administered using tricaine methanesulfonate (MS-222) at a concentration of 100 mg/L for all handling and sampling procedures to minimize stress and discomfort. Throughout the study, efforts were made to alleviate suffering by maintaining optimal water quality, providing appropriate nutrition, and minimizing handling times. Any fish showing signs of distress or illness were promptly euthanized using the above-mentioned humane method. 2.2. Experimental setup The third generation of the domesticated stock of O. bimaculatus was kept in circular tanks (12 feet diameter, 4 feet depth, 2000 litre water) for six months in triplicates, i.e., three tanks each in control and treatment groups. The stocking density was kept at 30 fish per tank, and proper water quality parameters were maintained to minimise environmental effects on the experiment. The control group were fed with an artificially formulated diet without adding any vegetable oil (Table 1). The treated group were fed a diet with the inclusion of vegetable oil at 3, 5, 7 and 9% for T1, T2, T3 and T4, respectively (Table 1). The vegetable oil used was produced by Ruchi Soya Pvt. Ltd., Raigad, India, that primarily consists of 90–95% refined soybean oil, enriched with 1–2% natural antioxidants such as Vitamin E, and 0.1–0.5% anti-foaming agents like Dimethylpolysiloxane. It also contains trace amounts of additives, including emulsifiers and stabilizers. Nutritionally, per 100g, the oil provides 884 kcal of energy and contains 100g of total fat, comprising 15g of saturated fat, 23g of monounsaturated fat, and 62g of polyunsaturated fat. The oil has zero trans fat and cholesterol, and it supplies 12mg of Vitamin E, meeting 80% of the daily value. The crude protein content was 30–35% in each feed. The best treatment among these, i.e., T2, was taken for transcriptomics analysis. Moreover, the relative fecundity, fertilisation rate, GSI (Gonado Somatic Index), HSI (Hepato Somatic Index), etc., were calculated based on the methods of earlier published work [14]. These parameters were calculated using ten fish specimens from each replicate. 10.1371/journal.pone.0309311.t001Table 1Formulation and composition of the experimental diets (in % per kg).IngredientsControlT1T2T3T4Fishmeal12020202020Soyabean10808080808Wheat bran11111111111Casein21818181818Gelatine255555White dextrin 21414141414Cellulose217.4814.4812.4710.468.46Vegetable oil 30003050709Vitamin Premix (Vit-E free)40202020202Mineral Premix40303030303BHT20.020.020.020.020.02Carboxymethyl cellulose 21.51.51.51.51.51Obtained from College of Fisheries, CAU, Lembucherra, Agartala, India.2Hi-media Laboratories, Mumbai, India.3Ruchi Soya Pvt. Ltd., Raighad, India.4Vitamin- Mineral Premix (per kg of diet): vitamin A, 2000 IU; vitamin B1 (thiamin), 5 mg; vitamin B2 (riboflavin), 5 mg; vitamin B6, 5 mg; vitamin B12, 0.025 mg; vitamin D3, 1200 IU; vitamin K3, 2.5 mg; folic acid, 1.3 mg; biotin, 0.05 mg; pantothenic acid; calcium, 20 mg; inositol, 60 mg; ascorbic acid (35%), 110 mg; niacinamide, 25 mg; MnSO4, 10 mg; MgSO4, 10 mg; KCl, 95 mg; NaCl, 165 mg; ZnSO4, 20 mg; KI, 1 mg; CuSO4, 12.5 mg; FeSO4, 105 mg; Na2SeO3, 0.1 mg; Co, 1.5 mg. Formulation and composition of the experimental diets (in % per kg). 1Obtained from College of Fisheries, CAU, Lembucherra, Agartala, India. 2Hi-media Laboratories, Mumbai, India. 3Ruchi Soya Pvt. Ltd., Raighad, India. 4Vitamin- Mineral Premix (per kg of diet): vitamin A, 2000 IU; vitamin B1 (thiamin), 5 mg; vitamin B2 (riboflavin), 5 mg; vitamin B6, 5 mg; vitamin B12, 0.025 mg; vitamin D3, 1200 IU; vitamin K3, 2.5 mg; folic acid, 1.3 mg; biotin, 0.05 mg; pantothenic acid; calcium, 20 mg; inositol, 60 mg; ascorbic acid (35%), 110 mg; niacinamide, 25 mg; MnSO4, 10 mg; MgSO4, 10 mg; KCl, 95 mg; NaCl, 165 mg; ZnSO4, 20 mg; KI, 1 mg; CuSO4, 12.5 mg; FeSO4, 105 mg; Na2SeO3, 0.1 mg; Co, 1.5 mg. 2.3. Sample collection and RNA extraction The ovary tissues were collected in triplicates from each group (control and T2) and kept at -20°C for qPCR analysis. The tissue samples were pooled from the control and treated group (T2) and were marked as PCO (Pabda Control Ovary) and PTO (Pabda Treated Ovary), respectively, for transcriptomics analysis. The tissue samples were kept in liquid nitrogen until RNA isolation. The total RNA was isolated by RNeasy Plus Universal Mini Kit (Qiagen, USA), as per the manufacturer’s protocol. The quality and quantity of the isolated RNA were checked using 1% denaturing RNA agarose gel and NanoDrop, respectively. 2.4. Library preparation and sequencing Library preparation was performed with Illumina TruSeq Stranded mRNA Sample Prep kit (Illumina, USA) according to the standard protocol set from the manufacturer. The RNA sample concentration used from both samples were 1355 ng/μl. The library quality was tested using Agilent 4200 Tape Station system (Agilent Technologies, USA). The Paired-end (PE) Illumina libraries were loaded onto NextSeq500 for cluster generation and sequencing using 2 x 75 bp chemistry. This PE sequencing allows the template fragments to be sequenced in both forward and reverse directions. The illumine kit reagents were used in the binding of samples to complementary adapter oligos on the PE flow cell. The adapters were designed to allow selective cleavage of the forward strands after re-synthesis of the reverse strand during sequencing. The copied reverse strand was used to sequence from the opposite end of the fragment. 2.5. de novo assembly and DE analysis The raw reads generated in fastq format were then taken for quality checking by FastQC v0.11.9 [15]. The low-quality reads (phred score < 30), Illumina adapters and any required overrepresented sequences for each sample were removed by quality trimming using Cutadapt v3.2 [16]. Sequence reads are available from the NCBI sequence read archive (SRA) under the accession number PRJNA705413. Trimmed reads were again checked for quality using FastQC v0.11.9 [15]. The final quality reads of all the samples were concatenated to a single file and loaded onto Trinity software package v2.11.0 [17] with default parameters to assemble high-quality reads into contigs. The Trinity package helped to reconstruct the transcripts and isoforms into their final form. The transcriptome assembly quality was checked using sanger-pathogens/assembly-stats v1.0.1 to generate standard metrics and N50 statistics. Mapping and abundance estimation for each sample were performed using the align_and_estimate_abundance.pl utility in Trinity [17] with default parameters, employing RSEM as the method for abundance estimation. The count tables generated for each sample were merged for further differential expression (DE) analysis using Trinity’s abundance_estimates_to_matrix.pl utility [17]. The merged RSEM isoform count matrix was also used for calculating fold changes between PCO and PTO by edgeR v3.32.1 [18] package in R. Additionally, Fragments Per Kilobase of Transcript per Million Mapped (FPKM) values for each sample were calculated using the run_TMM_normalization_write_FPKM_matrix.pl function in Trinity [17]. The percentage of reads assembled was computed using bowtie2 v2.4.2 [19], and the completeness of the assembly was assessed using BUSCO v5.0.0 [20] with the "Actinopterygii" lineage dataset (actinopterygii_odb10, 2021-02-19). BUSCO was run in transcriptome assembly mode. 2.6. Functional annotation and CDS prediction of differentially expressed transcript The coding transcripts from the de novo assembled transcripts were detected using TransDecoder v5.5.0. Then the functional annotation of the CDS was performed using DIAMOND (BLASTX alignment mode) v2.0.7 [21] to find the homologous sequences for the CDS against NR (non-redundant protein database) from NCBI. Reads of PCO and PTO were pooled to identify the CDS of each sample, and the reads from each of the samples were mapped on the final set of pooled CDS using BWA-MEM toolkit v0.7.17 [22]. The read count (RC) values were calculated from the resulting mapping, and those CDS with at least 85% coverage and 3X read depth were considered for downstream analysis for each sample. These FPKM values of the top 50 differentially expressed genes (DEGs) and reproductive genes were used for heatmap generation between PCO and PTO using gdata v2.18.0 [23] and pheatmap v1.0.12 [24] package in R. Among the top 50 DEGs, 25 were taken as up-regulated and 25 as down-regulated. Log2 Fold Change was calculated for further analysis of differential expression of each transcript between PCO and PTO by taking the log of PTO FPKM vs PCO FPKM value. All the DEGs with p-value <0.05 and log2 fold changes were taken for volcano plot generation in gdata v2.18.0 [23] and gplots v3.1.1 [25] package in R. 2.7. Gene ontology (GO) and KEGG pathway mapping The DEGs were taken for GO and KEGG pathway determination on shinyGO v0.61 [26], taking a p-value cut-off of 0.05. All the genes were analysed against three GO categories, i.e., Biological Process, Cellular Component and Molecular Function. The output of shinyGO analysis was plotted in the WEGO plot [27]. 2.8. qPCR validation The QuantStudio™ 5 Real-Time PCR (Applied Biosystems, USA), based on SYBR green chemistry, was used to validate candidate genes related to reproduction. The gene-specific primers were designed based on transcriptomics data. The gonad tissues were sampled from both PCO and PTO in triplicates. Total RNA was isolated from all the tissues, using Quick-RNA Miniprep Plus Kit (Zymo Research, USA) and cDNA was prepared, using iScript™ cDNA Synthesis Kit (Bio-Rad, USA) as per the manufacturer’s protocol. qPCR reaction was performed by adding 5 μl of SYBR green master mix (Thermo Scientific, USA), forward and reverse gene-specific primers 1 μl each (1 pmol/μl), 1 μl of template cDNA (1 μg/μl) and nuclease-free water to make it up to a total volume of 10 μl. The. β-actin was taken as an internal control for expression level normalisation. Three technical replicates were made for each sample during qPCR. The analysis was done by the method of Pfaffl [28]. 2.9. Statistical analysis Differentially expressed genes (DEGs) were identified, and statistical significance (p-value <0.05) was determined. Heatmaps and volcano plots of DEGs were created using gdata v2.18.0, pheatmap v1.0.12, and gplots v3.1.1 packages in R. Gene ontology (GO) and KEGG pathway analysis were performed using shinyGO v0.61 with a p-value cut-off of 0.05. The qPCR validation involved analyzing gene expression in triplicates with QuantStudio™ 5 Real-Time PCR. The statistical significance was assessed, and results were reported as mean ± standard error. 3. Results 3.1. Wet-lab experiment The fertilisation rate and GSI were found to be highest for the T2 group of fishes i.e. averaging 80.02 and 23.83, respectively (Table 2). Interestingly, the HSI was found to be the lowest for T2 i.e. averaging 0.65 (Table 2). The relative fecundity was found to be highest for T2 and T3 groups, averaging 756.66 eggs/g body weight. From all the calculations, the T2 group was the best treatment, and no mortality was seen in any experimental group except T3. The T2 was identified as the best treatment for transcriptomics analysis based on several parameters observed in Table 2. The relative fecundity of T2 was significantly higher (743.39±2.50, 778.12±2.44, 749.16±3.6 eggs/g body weight) compared to other treatments and the control group. Additionally, T2 showed an improved fertilization rate (81.07±1.93, 79.00±2.06, 79.99±1.83%) and a notably higher Gonado Somatic Index (GSI) (24.46±1.07, 23.80±0.02, 23.25±0.40), indicating better reproductive health and development. 10.1371/journal.pone.0309311.t002Table 2Different parameters of female O. bimaculatus brood fed with diets containing varying levels of lipid.Three biological replicates (R1, R2 and R3) in each treatment were taken. In each biological replicate, ten fish specimens were analysed. The values are represented as mean ± Standard Error (S.E.).ParametersCR1CR2CR3T1R1T1R2T1R3T2R1T2R2T2R3T3R1T3R2T3R3T4R1T4R2T4R3Relative Fecundity (Eggs/g body weight)399.55±5.39385.12±1.3345.21±2.12486.19±4.42456.56 ±4.5477.23±1.33743.39±2.50778.12±2.44749.16±3.6754.46±4.31789±5.6753.45±4.21610.47±4.28612.21±5.2608±4.55Weight of each egg (mg)0.08±0.000.07±0.000.07±0.000.07±0.000.07±0.000.06±0.000.08±0.000.08±0.000.07±0.000.08±0.000.08±0.000.07±0.000.07±0.000.06±0.000.07±0.00Volume of Eggs/gm of fish1.13±0.041.11±0.011.09±0.051.74±0.051.68±0.021.66±0.042.08±0.052.05±0.031.99±0.021.82±0.041.72±0.011.79±0.021.75±0.071.79±0.041.70±0.06Fertilization rate51.27±2.0848.07±1.0850.27±1.1257.03±4.5653.15±1.0556.21±2.0181.07±1.9379.00±2.0679.99±1.8377.29±1.3375.20±1.0972.27±2.1062.84±2.0358.02±1.0459.30±1.44GSI (Gonado somatic Index)10.70±0.6110.12±0.510.50±0.2312.82±0.5612.05±0.4512.02±0.724.46±1.0723.80±0.0223.25±0.4021.84±0.3921.20±0.0321.50±0.6116.06±1.2016.26±0.516.98±0.26HSI (Hepato Somatic Index)0.96±0.030.97±0.050.87±0.020.80±0.030.76±0.010.78±0.020.65±0.040.63±0.030.65±0.020.67±0.010.66±0.030.64±0.050.74±0.030.74±0.010.68±0.04 Different parameters of female O. bimaculatus brood fed with diets containing varying levels of lipid. Three biological replicates (R1, R2 and R3) in each treatment were taken. In each biological replicate, ten fish specimens were analysed. The values are represented as mean ± Standard Error (S.E.). 3.2. RNA-Seq data analysis The data generated for PCO and PTO were found to be 6.37 and 4.56 Gb, respectively. The total number of reads for PCO and PTO were found to be 42,479,658 and 30,366,474, respectively. The Trinity analysis generated 150,836 pooled transcripts with maximum and minimum transcript lengths of 16,683 and 201, respectively. The completeness of the BUSCO analysis on the present transcriptomic dataset was found to be 81%. Out of the total 2950 complete BUSCOs (C), 2488 complete and single-copy BUSCOs (S) and 462 complete and duplicated BUSCOs (D) were found. Moreover, 75 Fragmented BUSCOs (F) and 615 missing BUSCOs (M) were found in 3640 total BUSCO groups searched from the actinopterygii_odb10 dataset. The GC content was 47.24%. In total, 99.28% of the reads were assembled. The present transcriptomics showed maximum BLAST hits with Pangasianodon hypophthalamus, Ictalurus punctatus and Tachysurus fulvidraco. The total number of CDS for PCO and PTO were found to be 18,421 and 17,830, respectively. The volcano plot for all the DEGs in the dataset has been shown in Fig 1. The heatmap for the top 50 DEGs has been shown in Fig 2. The GO analysis for the DEGs (WEGO plot) has been shown for PCO and PTO in Fig 3a and 3b, respectively. We found candidate genes related to reproduction among the top 50 DEGs. But in addition to this we found other genes related to reproduction in the transcriptomics data, which were differentially expressed. Volcano plot showing top up and down-regulated genes. Up-regulated and down-regulated genes are marked with red and blue dots, respectively. The logFC and -log10 adjusted p-values were plotted using R. Heatmap showing top 50 up and down-regulated genes. FPKM values of the top 50 DEGs and reproductive genes were used for heatmap generation between PCO and PTO using R. Gene ontology enrichment analysis of DEGs for a. PCO and b. PTO. DEGs described were analyzed for enrichment in three GO categories i.e. biological process, cellular component, and molecular function. 3.3. qPCR analysis The qPCR validation of candidate genes related to reproduction supported the differential expression patterns analysed in the transcriptomics data. The stard3, SF1-A, cyp19a1a, rxrba, rxrbb, rxrga, egr2a, cyp17a1, hsd3b, etc. were differentially expressed in the gonad tissues. The aqp3a and cyp17a1 were found to be the top down-regulated gene. Similarly, hsd3b, ar and hsp70.1 were found to be the top up-regulated gene in T2. The average of technical replicates for each biological replicates have been shown in the present study. The differential expressions are shown as log2 fold changes than control in Table 3. 10.1371/journal.pone.0309311.t003Table 3Differential expression of candidate genes related to reproduction in PTO (T2 group of fishes).The transcriptomics data are shown as log2 fold changes than PCO with their respective p-values. Similarly, qPCR values are shown as log2 fold changes ± S.E. than PCO in three biological replicates, i.e., T2R1, T2R2 and T2R3. Down-regulated Gene name Gene symbol Transcriptomics qPCR log2 Fold Change p-value log2 Fold Change ± S.E. T2R1 T2R2 T2R3 Spermatid perinuclear RNA-binding protein strbp-002 -1.860.0021870.47±0.040.41±0.070.36±0.05Estrogen receptor esr1 -2.200.0021890.42±0.080.49±0.060.41±0.02Steroid 17-alpha-hydroxylase/17,20 lyase cyp17a1 -1.461.00E-050.19±0.030.18±0.040.23±0.03Aquaporin-4 aqp4 -2.160.0030440.66±0.040.63±0.060.66±0.03Estradiol 17-beta-dehydrogenase 1 hsd17b1 -2.170.0029530.48±0.040.48±0.060.51±0.06Membrane-associated progesterone receptor component 1 pgrmc1 -2.147.54E-050.76±0.030.79±0.040.74±0.07Aquaporin-3a aqp3a -2.130.0033420.16±0.030.17±0.020.21±0.05Retinoic acid receptor alpha raraa -2.130.0041960.53±0.080.52±0.070.52±0.08Follicle-stimulating hormone receptor fshr -2.101.65E-070.64±0.040.69±0.050.63±0.02Bromodomain testis-specific protein brdt -2.097.30E-070.44±0.060.46±0.050.49±0.03Retinoic acid receptor RXR-gamma-B rxrgb -2.080.0040810.48±0.070.47±0.040.44±0.05Lutropin-choriogonadotropic hormone receptor lhcgr -2.079.13E-060.39±0.070.39±0.040.37±0.03Follistatin fsta -1.909.22E-060.33±0.060.31±0.040.31±0.03 Up-regulated Gene name Gene symbol Transcriptomics qPCR log2 Fold Change ± S.E. log2 Fold Change p-value T2R1 T2R2 T2R3 Thyroid hormone receptor-associated protein 3 thrap3b 2.020.0021513.47±0.073.49±0.093.55±0.11Cytochrome P450 cyp19a1a 2.101.47E-052.42±0.082.39±0.032.48±0.09Spermatid perinuclear RNA-binding protein strbp 2.110.0035633.23±0.033.19±0.043.18±0.07Aquaporin FA-CHIP-like aqp7 2.130.0030233.69±0.043.66±0.063.74±0.04Retinoic acid receptor RXR-beta-B rxrbb 2.130.0040231.48±0.061.44±0.051.41±0.03Steroidogenic factor 1 nr5a1a 2.200.0037732.44±0.072.44±0.112.41±0.13Retinoic acid receptor RXR-beta-A rxrba 1.330.0028261.41±0.041.47±0.051.47±0.073 beta-hydroxysteroid dehydrogenase/Delta 5—4-isomerase hsd3b 2.149.04E-054.24±0.074.16±0.114.25±0.09Membrane-associated progesterone receptor component 2 pgrmc2 1.942.90E-052.19±0.042.19±0.032.21±0.05Androgen receptor ar 1.530.003584.43±0.134.39±0.094.39±0.05Progesterone receptor pgr 2.111.89E-053.21±0.053.27±0.043.23±0.06Estradiol 17-beta-dehydrogenase 2 hsd17b2 1.840.0029514.49±0.094.44±0.074.44±0.03D(1A) dopamine receptor drd1a 1.887.58E-072.49±0.082.43±0.052.47±0.04Retinoic acid receptor RXR-gamma-A rxrga 1.920.0018851.42±0.081.42±0.081.46±0.09Epidermal growth factor egf 2.090.0028263.34±0.113.36±0.073.34±0.03Transforming growth factor alpha tgfa 1.899.04E-052.66±0.062.73±0.092.63±0.03Insulin like growth factor 1 igf1 1.972.90E-051.88±0.051.89±0.041.89±0.05Insulin like growth factor 2a igf2a 2.140.003583.47±0.053.52±0.073.42±0.09Insulin like growth factor 3 igf3 2.020.0037731.56±0.041.49±0.051.56±0.07Nuclear receptor subfamily 5, group A, member 1a/ steroidogenic factor 1 SF1-A 2.150.0028263.33±0.073.29±0.033.28±0.05Heat shock cognate 70-kd protein, tandem duplicate 1hsp70.12.112.90E-054.23±0.094.14±0.114.17±0.11Star-related lipid transfer (START) domain containing 3 stard3 2.280.0001223.12±0.063.07±0.043.15±0.11Retinoic acid receptor RXR-gamma-B rxrgb 2.080.0040811.46±0.061.48±0.051.41±0.09 Differential expression of candidate genes related to reproduction in PTO (T2 group of fishes). The transcriptomics data are shown as log2 fold changes than PCO with their respective p-values. Similarly, qPCR values are shown as log2 fold changes ± S.E. than PCO in three biological replicates, i.e., T2R1, T2R2 and T2R3. 4. Discussion The present study investigates the molecular effects of vegetable oil on the female reproductive process in O. bimaculatus. Previous research has highlighted the positive impact of dietary lipids on ovarian development [29–32]. The vegetable oils (Ruchi Soya Pvt. Ltd., Raigad, India), which are rich in ω3 and ω6 fatty acids and fortified with vitamins A, D, E, and K, offer substantial nutritional benefits. In this study, reproductive indices demonstrated significant improvements in fish treated with vegetable oil compared to the control group. The Gonado Somatic Index (GSI) was markedly higher in the treated group, indicating enhanced ovarian development facilitated by the components of vegetable oil. Furthermore, the relative fecundity was significantly elevated in the treated group, suggesting that vegetable oil supplementation effectively increased the number and quality of oocytes. Another important parameter measured in this study is the Hepatosomatic Index (HSI), which reflects ovarian status by indicating the developmental process of oocytes, as vitellogenesis occurs in the liver. In most teleost, the HSI is higher during the initial ripening of the ovary and decreases toward final maturation [33]. This pattern occurs because the liver is heavily involved in vitellogenesis during the initial phase, with most stored energy being diverted toward ovarian development as the process progresses [33]. A significant decrease in HSI was observed in the treated group, suggesting more efficient ovarian development. Comparative transcriptomics was conducted to analyze the molecular differences between fish fed a regular diet and those fed a vegetable oil-enriched diet. This approach allowed for the identification of several essential genes involved in ovarian development and vitellogenesis. These genes play critical roles in processes such as hormone regulation, oocyte maturation, and energy allocation for reproductive activities. The transcriptomic analysis revealed distinct differential expression patterns of these genes in fish fed the vegetable oil-enriched diet compared to those on the regular diet. To validate these findings, qPCR analysis was performed on the same genes, confirming the differential expression patterns observed in the NGS data. The consistency between the qPCR results and the NGS data strengthens the reliability of the transcriptomic findings. The regulation of these genes aligned with the improved reproductive indices observed in the vegetable oil-treated group, such as higher GSI and increased relative fecundity. These molecular insights provide a comprehensive understanding of how vegetable oil supplementation enhances ovarian development and overall reproductive performance in O. bimaculatus. This study underscores the potential of dietary interventions in aquaculture to improve broodstock quality and reproductive success. STAR gene (stard3) is the initiator of ovarian steroidogenesis in fish [34]. The star protein transports cholesterol to the inner mitochondrial membrane, where steroidogenesis begins with converting cholesterol to pregnelone. The stard3 gene was upregulated in the fishes fed with vegetable oil compared to the control group of fishes. This gene is also among the top 50 differentially expressed genes in the present transcriptomics data. Vegetable oils contain a higher proportion of linoleic acid, which enhances steroidogenesis in vertebrates [35]. Vegetable oil contains a high amount of palmitic acid precursor of palmitoylethanolamide (PEA) [36]. This PEA is responsible for the synthesis of star protein. This might be the reason for the increase in the production of star protein. Another essential gene that regulates stard3 is the steroidogenic factor 1 (SF1-A). This gene was also found to be upregulated in the treatment group of fish. Vegetable oils have a higher amount of linoleic acid that enhances ovarian physiology. In the present study, the cyp19a1 gene was found to be upregulated. In some fishes, down-regulation of this gene disrupts the ovarian process and leads to testicular development [37]. The cyp19a1 shows stage-specific expressions in zebrafish and has been found abundantly in the follicular layer of vitellogenic oocytes [38]. This suggests that cyp19a1 plays a significant role in vitellogenesis and its upregulation depicts its role in enhancing the vitellogenesis process. Genes involved in the retinoid signalling pathways, specifically rxrba, rxrbb, and rxrga, exhibited up-regulation in the treatment group of fish. In females of higher vertebrates, retinoic acid signalling plays a major role in folliculognesis and affects the number and quality of oocytes [39]. Vegetable oils are fortified with vitamin A, which is the source of retinoic acid. This retinoic acid enhances the retinoid signalling pathway, thereby improving the female reproductive performance. It has been found in previous studies that hsd17b, which is an essential factor in ovarian steroidogenesis, is positively regulated through the retinoic acid signalling pathway [40]. Higher production of hsd17b2 is induced by retinoic acid. In the present analysis, hsd17b2 was up-regulated. This gene is responsible for the interconversion of Estrone (E1) to Estradiol (E2) [41]. In the present study, 17β-estradiol receptor (esr1) was down-regulated, suggesting that E1 is getting converted to E2. E2 is the main regulatory factor for vitellogenesis and the final maturation of the oocyte. Although E2 is produced by the conversion of both testosterone and E1, the major pathway traversed its production is the E1 signalling pathway rather than the testosterone [42]. The E2 binds to globulin in the blood and traverses to the liver for vitellogenesis. The down-regulation of esr1 in the treated fishes also suggests that, its expression is stage and site specific in ovary. The classical pathway in steroidogenesis involves the breakdown of cholesterol into pregnelone, after which the hydroxylation of pregnelone results in the formation of 17α-OH-progesterone. This involves cyp17a1 and hsd3b, both of which were up-regulated in the present study. The conversion into 17α-OH-progesterone into 17α-20β-dihydroxy-4-pregnen-3-one requires hsd20b, which was found to be up-regulated in the treatment group of fishes. Other vital genes involved in enhancing oocyte maturation, such as egf and tgfa, were also found up-regulated in the treatment group of fishes, which suggests that vegetable oil enhances the process of vitellogenesis and accelerates final oocyte maturation [43]. Interestingly, the cyclin-dependent kinase family genes mainly were found up-regulated in the present study. The highly up-regulated cdk2, also known as active MPF (maturation promoting factor), indicates that the incorporation of vegetable oil enhanced the maturation process of the ovary. The CDKs are primarily associated with cell differentiation and proliferation, which also holds true for germ cells [44]. Since the oocytes are in developing stages, CDKs (cdk1, cdk2, cdk13, cdk15 and cdk16) were up-regulated in the present study. During the folliculogenesis of the oocytes, testosterone and 11-ketotestosterone, which are primarily associated with male steroidogenesis, also have important roles. These two androgens express in a stage-specific manner in the ovary and stimulate cortical alveoli production [45]. Therefore, androgen receptors show increased expression in the ovary during folliculogenesis. It has been studied that androgen receptor antagonist, when administered, induces early follicular atresia and inhibits growth responses in oocytes [46]. The progesterone receptor was found to be up-regulated in the present experiment. This indicates that increased intake of dietary lipids enhanced the expression of both androgen and progesterone receptors, thereby aiding ovarian development. A higher amount of linoleic acid in the vegetable oils enhanced ovarian steroidogenesis. Treating with linoleic acid increases the expression of insulin-like growth factors (IGFs) in higher vertebrates [47]. In the present study, the insulin-like growth factors (1,2 and 3) were also up-regulated significantly. The igf1 and igf2 are found in the liver and gonads of vertebrates. However, igf3 is known to be found only in fish and is gonad-specific. The igf1 promotes oocyte maturation and proliferation, whereas igf2 has a more specific role in folliculogenesis and exhibits germinal vesicle breakdown (GVBD). The igf3 also has similar functions in teleosts. In some fishes like the killifish, it has been found that IGFs are more potent in stimulating oocyte maturation than 17a-20b-dihydroxy-4-pregnen-3-one (MIS) [48]. In the present study, specific genes responsible for the inhibition of oocyte maturation were significantly downregulated. Among these genes, the follistatin group (fsta) was notably reduced in expression. Follistatin is a critical regulatory protein in the epidermal growth factor (egf) and transforming growth factor-alpha (tgfa) pathways [49]. The egf is known to accelerate oocyte maturation, while follistatin can inhibit this process by blocking the EGF pathway, thus acting as an oocyte maturation inhibitor. The significant down-regulation of the fsta gene in the treated group of fish suggests that the incorporation of vegetable oil in the diet enhances the factors responsible for promoting oocyte maturation while reducing the inhibitory factors. This dietary intervention appears to create a more favourable molecular environment for oocyte development by reducing the expression of inhibitors like follistatin. Consequently, the treated group experiences an up-regulation of pathways that support oocyte maturation. Additionally, while tgfa is known to facilitate oocyte maturation, its counterpart, transforming growth factor-beta (tgfb), inhibits this process [50]. The findings indicate that vegetable oil supplementation enhances the positive regulators (such as tgfa and egf) of oocyte maturation and simultaneously down-regulates negative regulators (such as follistatin and potentially tgfb). This dual action likely contributes to the observed improvements in ovarian development and reproductive indices in the treated group of fish. Another important gene related to reproduction is the hsp70 binding protein. Since hsp70 is found in the gonads, it can not be ignored that it modulates reproductive stress. In higher vertebrates, it has been found that igf1 and fsh can reduce the expression of hsp70 and reduce thermal and nutritional stress effects on the ovary [51], which might be the reason behind the down-regulation of hsp70 in the treatment group of fish. Since the expression of both igf1 and hsp70 were significantly higher in the present study, it can be stated that there is little or no reproductive stress. Similarly, RAS-like estrogen-regulated growth inhibitor (rerg) that inhibits cellular proliferation was significantly down-regulated in the treatment group of fish. There is a significant down-regulation of the EGR group of genes (egr1 and egr2a). These genes are highly expressed during stress, apoptotic signalling and tissue damage [52, 53]. The above findings suggest that incorporating fortified vegetable oils can prove highly beneficial for oocyte maturation and ovarian development. It improves ovarian steroidogenesis at a molecular level and maintains ovarian physiological processes. 5 Jul 2024 PONE-D-24-14273Effect of vegetable oil on ovarian steroidogenesis- A transcriptome approach to understand molecular mechanisms of hypothalamus pituitary and gonad axis in Ompok bimaculatusPLOS ONE Dear Dr. Sundaray, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Specific comments by the academic editor are included in the attached filesThe quality of the figures need to be modified. Please submit your revised manuscript by Aug 19 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Amel Mohamed El Asely Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" 2. To comply with PLOS ONE submissions requirements, in your Methods section, please provide additional information regarding the experiments involving animals and ensure you have included details on (1) methods of sacrifice, (2) methods of anesthesia and/or analgesia, and (3) efforts to alleviate suffering. 3. Thank you for your submission to PLOS ONE. We note that your study design may include death of a regulated animal as a likely outcome or planned experimental endpoint. At this time, we request that you please report additional details in your Methods section regarding animal care and use for the survival study, as per our editorial guidelines (http://journals.plos.org/plosone/s/submission-guidelines#loc-humane-endpoints). For easy reference, we have attached a checklist that may be relevant for your submission. Please complete all items on the checklist at the following link: http://journals.plos.org/plosone/s/file?id=bb1d/plos-one-humane-endpoints-checklist.docx Please upload the completed checklist as file type “Other” when resubmitting your manuscript. This document is for internal journal use only and will not be published if your article is accepted. We very much appreciate your attention to these requests and support of improved reporting standards in PLOS ONE submissions. 4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thanks for your hard efforts. Please check the following comments 1- The abstract contains a lot of abbreviations that need to be rewritten fully (GSI, HIS, DEGs, HPG). 2- In the introduction section, the part between lines 58-66 needs to be rewritten to organize the aims of the study (please make the aims more direct) 3- In lines 76-77, what do you mean by; three tanks each in control and 77 treatment groups? Does that mean 3 tanks for each group? 4- What is the vegetable oil that has been used in this study? Mention its source and commercial data. 5- In lines 79-80 the mention of Table 1 here is not correct, it should be Table 3 instead. The table 1 should be in the results section. In addition, in the result section the author used Table 2 in describing the results of the fertilization rate and GSI that were described in Table 1, not Table 2. 6- In line 81 how did you know that the best treatment among these, i.e., T2 7- In line 88, what is the meaning of PTO and PCO? 8- How did you analyze the data statistically 9- In lines 155 – 156 please replace Table 2 with Table 1. 10- In line 181 Table 3 with Table 2. 11- In line 185 please replace the symptoms w3 and w6 with ω3 and ω6. 12- The discussion section needs to be rewritten (please do not repeat the results in the discussion) Reviewer #2: Title: Please modify Title; You have not addressed the source of vegetable oil in Abstract, and M&M. Please add this to The Title, Abstract, and M&M. And in the title add HPG following Hypothalamus Pituitary Gonadal axis Please modify "Jitendra Kumar Sundaray and Janmejay Parhi should be considered as joint corresponding author" to Jitendra Kumar Sundaray and Janmejay Parhi are equally responsible as corresponding Author. Abstract: Line 31 Please specify the source of vegetable oil Line 33 Please indicate the full form of abbreviated words when the first appear in the text, i.e. GSI and HSI. Introduction: Line 42 change gonad to gonads Line 43 change muscle to muscles Line 50 change like to including Line 56 change Fish to fish Line 64 change So to therefore M&M Line 112 please revise and edit Line 118 as above Results OK Discussion: Line 183 Please replace "depict" with an appropriate verb. Depict means represent by a drawing, painting, or other art form. Again, Please indicate the source of vegetable oil. Line 184 change "Several studies earlier describe" to Several earlier studies showed.. Line 184 Several studies earlier describe the beneficial effects of dietary lipid on ovarian development (29-32). In which species? Line 185 please correct omega symbol Line 186 vitamins Line 186 change gave a better result to gave a better understanding Line 191 please revise. The writing style needs professional check. Line 221 please revise Line 267 can hence what? Line 273 it can not ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Reza Masoumi, A/Prof of Animal Physiology ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. Submitted filename: comment.docx Submitted filename: PONE-D-24-14273 (Editor).pdf 12 Jul 2024 We have addressed the reviewer comments in response to reviewer file. In addition to this the ethical consideration statements have been mentioned well as per plosone requirements. Moreover the plos-one-humane-endpoints-checklist.docx has been uploaded along with the revised manuscript. Submitted filename: Response_to_Reviewers.docx 9 Aug 2024 Effect of vegetable oil on ovarian steroidogenesis- A transcriptome approach to understand molecular mechanisms of hypothalamus pituitary and gonad axis (HPG) in Ompok bimaculatus PONE-D-24-14273R1 Dear Dr. Jitendra Kumar, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Amel Mohamed El Asely Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thanks for the hard work. Your paper has a novel idea, good methodology, and well written. The reviewing items that I have asked are completely answered. Good luck ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: AHMED ELKHAWAGAH ********** 26 Sep 2024 PONE-D-24-14273R1 PLOS ONE Dear Dr. Sundaray, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Amel Mohamed El Asely Academic Editor PLOS ONE